Search for: "UPS, Inc." Results 4121 - 4140 of 43,751
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Apr 2022, 3:57 pm by Eugene Volokh
From Eleventh Circuit Judge Stanley Marcus's concurrence in Speech First, Inc. v. [read post]
21 Apr 2022, 9:07 am by Eugene Volokh
If the owner put up a sign advertising a new coffee drink, the sign would be classified as on-premises, but suppose the owner instead mounted a sign in the same location saying: "Contribute to X's legal defense fund" or "Free COVID tests available at Y pharmacy" or "Attend City Council meeting to speak up about Z. [read post]
20 Apr 2022, 6:03 pm by bvernia
According to DOJ’s press release: Springbok Health Inc., a medical clinic with locations in Colorado Springs and Pueblo West, Colorado, and Mark Jankelow, Springbok’s owner and Chief Executive Officer, have agreed to pay at least $125,000, and up to as much as $335,494, to resolve allegations they violated the False Claims Act by billing Medicare and Medicaid for high-complexity and prolonged medical evaluation and management services when such services were… [read post]
19 Apr 2022, 11:14 pm by Jon L. Gelman
Joshua Herion – who does business as ECS Roofing Professionals Inc. [read post]
19 Apr 2022, 12:37 pm by Bernard Bell
”  The withheld material included “TRIG specific model questions that USCIS immigrations officers should ask” and “follow-up questions that immigration officers should ask when they spot issues. [read post]
19 Apr 2022, 6:51 am by Michael Fausey
§ 4041(b)(3) (providing for civil penalties up to $55,000 for a first violation and up to $110,000 for any subsequent violations). [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
 The CMPL carries penalties of up to $50,000 per kickback, in addition to three times the amount of the remuneration. [read post]
18 Apr 2022, 12:15 pm by Tom Lamb
We start with an April 15, 2022 Dow Jones piece, "TG Therapeutics Pulls Sole Product Ukoniq Amid Increased Death Risk", which sets the stage for some more in-depth analysis of events leading up to this Ukoniq recall: TG Therapeutics Inc. on Friday said it is pulling its Ukoniq lymphoma treatment from the market after a study showed a possible increased risk of death in patients taking the drug. [read post]